Glycovax Pharma launches a highly performant SLA Adjuvant
Glycovax Pharma Begins Large-Scale Commercial Production
of SLA adjuvant through an exclusive worldwide license with the
National Research Council of Canada (NRC)
Glycovax Pharma Begins Large-Scale Commercial Production
of SLA adjuvant through an exclusive worldwide license with the
National Research Council of Canada (NRC)